ARKG vs SPEM
ARK Genomic Revolution ETF vs SPDR Portfolio Emerging Markets ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SPEM—
SPDR Portfolio Emerging Markets ETF
Low-cost emerging-market equity exposure.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SPEM |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | State Street |
ARKG top holdings
Holdings data unavailable for ARKG.
SPEM top holdings
Holdings data unavailable for SPEM.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SPEM
SPEM (SPDR Portfolio Emerging Markets ETF) is Low-cost emerging-market equity exposure.